Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
about
Branched-chain amino acids for people with hepatic encephalopathyBranched-chain amino acids for people with hepatic encephalopathyTHDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapyNew technologies - new insights into the pathogenesis of hepatic encephalopathy.Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.Intestinal and hepatic metabolism of glutamine and citrulline in humans.Keratinocytes as depository of ammonium-inducible glutamine synthetase: age- and anatomy-dependent distribution in human and rat skin.Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats.Plasma Glutamine Concentrations in Liver Failure.Hepatic encephalopathy: an updated approach from pathogenesis to treatmentHuman splanchnic amino-acid metabolism.Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.Pharmacotherapy of hepatic encephalopathy in cirrhosis.Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?Mammalian glutaminase isozymes in brain.Pathogenesis of hepatic encephalopathy: lessons from nitrogen challenges in man.Branched-chain amino acids and muscle ammonia detoxification in cirrhosis.Ornithine phenylacetate revisited.The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus.Branched-chain amino acids for people with hepatic encephalopathy.Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study.Hepatic encephalopathy: An approach to its multiple pathophysiological features.Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosisProtein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.Current concepts in the pathophysiology and management of hepatic encephalopathy.Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis.The effect of portacaval anastomosis on the expression of glutamine synthetase and ornithine aminotransferase in perivenous hepatocytes.Urinary ammonia excretion increases acutely during living donor liver transplantation.Effect of parvoviral enteritis on plasma citrulline concentration in dogs.The gut does not contribute to systemic ammonia release in humans without portosystemic shunting.L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway.L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis.Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.Interventions to improve physical function and prevent adverse events in cirrhosis.Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis.Changes in CNS cells in hyperammonemic portal hypertensive rats.A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans.
P2860
Q24187134-9E1D6F21-5C38-4C42-B398-37841DCE6F94Q24187960-9D68CA29-05D2-4794-A231-396DA2D2A5BBQ28543895-9532BF4A-9DC1-4782-BEA5-A6AEF865B46AQ31134437-062507D5-AE6E-4E59-B094-74618C22386BQ31135843-AD31F29B-78E6-41C8-A99A-59F24F579287Q33277507-0D86909F-83D2-46C1-B773-D9C980650A42Q33407201-3D6006FF-BC7E-4C87-9FAD-6985B40CBA95Q35929182-FC1F4FF9-C845-4FA6-AF4B-8997F92A9858Q35944467-5847098F-6C98-49A4-BB5F-5D47539DDFB8Q36473777-9AB06378-D6CE-4D03-B4A3-9B2BD67C91CEQ37590615-E3BCAC02-2D4E-4794-8E77-72467C6B0D19Q37627757-BEAD0D73-72AD-4537-9232-1344365D1793Q37729173-C65CA59F-A4D8-4DC3-8ADC-3DBAA84486C5Q37852604-0DF60545-175F-4215-924B-885F8812CE88Q38059623-9BD0DA05-C912-4D9D-B557-F92FB1A1FC49Q38062487-4DB3D1B4-41A4-4926-9CF0-FD8E134572D5Q38073719-98578CDE-9C48-4007-8237-097F93CE0389Q38086119-D6A8AC0E-D6EF-4FB2-B2D2-77CA40867DFEQ38087547-E6C1A487-D722-4F14-BDB7-FCC11E777684Q38778053-98F744E5-99CF-4F37-A9E9-622BE90D13D6Q39331034-40781DC5-588B-42D2-A177-C106A4FDBB27Q41813389-EEF96878-E3CD-467E-8D1B-DCF3370903B0Q41820650-A0935360-1267-4920-8A6C-4BE674B9D3DEQ42694796-7DAFC8FA-6863-4634-B9B0-6EADDF232A1DQ42732353-035BF59B-7317-47A4-853E-0B2E1526FD75Q42781012-82CA7ED6-AB74-47F6-AC54-71519AD78D86Q43679416-2C8DF340-102B-4D0E-97CF-F4BA16E457D7Q44029547-482D0BA9-B7CF-43DA-B755-3E7E49DF69BFQ44147974-6345A2EC-0CE1-432A-B982-1DDFE5D56C85Q44318969-E3C2C07A-EFC2-493B-97FE-A149EC3E611DQ44410285-8EB2360A-9C20-40DF-A9D1-2E93878A723FQ45147300-E72A3D73-B63F-47FE-B9DA-7A6C234AD694Q45953607-A14B1921-29D9-45E8-B370-8CBBD57C301EQ46964120-E9946851-612B-4B0C-8998-9A36A548E1C9Q48083894-AAB4444B-2FCF-417B-A7AB-D604C962853CQ48260788-26900A90-8F7D-44A7-A2FF-D9376CDE923DQ50233423-6EEF438B-A1AD-4F02-BE93-A6B1D970A39CQ51820582-F2D1DF06-24B3-4298-8179-E775E33E7A1AQ53347703-B603DFA0-B798-46DF-B323-A44F3E19C537Q54920225-EDA83BDA-395C-4FCA-A504-CA90DA7AC1A8
P2860
Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Interorgan ammonia and amino a ...... ts with cirrhosis and a TIPSS.
@en
Interorgan ammonia and amino a ...... ts with cirrhosis and a TIPSS.
@nl
type
label
Interorgan ammonia and amino a ...... ts with cirrhosis and a TIPSS.
@en
Interorgan ammonia and amino a ...... ts with cirrhosis and a TIPSS.
@nl
prefLabel
Interorgan ammonia and amino a ...... ts with cirrhosis and a TIPSS.
@en
Interorgan ammonia and amino a ...... ts with cirrhosis and a TIPSS.
@nl
P2093
P356
P1433
P1476
Interorgan ammonia and amino a ...... ts with cirrhosis and a TIPSS.
@en
P2093
Doris N Redhead
Peter B Soeters
Peter C Hayes
Rajiv Jalan
Steven W M Olde Damink
P304
P356
10.1053/JHEP.2002.36497
P407
P577
2002-11-01T00:00:00Z